Neurogene Price Chart
Neurogene Volume Chart
Neurogene Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
+1.61(+8.27%)
| Open | $19.40 |
|---|---|
| Close | $21.01 |
| Low | $18.81 |
| Low Change | -0.59 (-3.04%) |
| High | $21.50 |
| High Change | +2.10 (+10.82%) |
| Range | $2.69 |
| Volume | 257.47K |
| Dollar Volume | $5.41M |
Premarket
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $19.36 |
|---|---|
| Close | $19.36 |
| Low | $19.36 |
| Low Change | 0.00 (0.00%) |
| High | $19.36 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 305 |
| Dollar Volume | $5.90K |
Regular Trading Hours Yesterday
+0.05(+0.23%)
| Open | $19.31 |
|---|---|
| Close | $19.36 |
| Low | $18.77 |
| Low Change | -0.54 (-2.80%) |
| High | $19.87 |
| High Change | +0.56 (+2.90%) |
| Range | $1.10 |
| Volume | 84.589K |
| Dollar Volume | $1.64M |
Premarket Yesterday
*No Trades in Segment
Neurogene Moving Averages
| 5 Day Moving Average (SMA5) | $19.63 |
|---|---|
| 10 Day Moving Average (SMA10) | $20.98 |
| 20 Day Moving Average (SMA20) | $21.32 |
| 50 Day Moving Average (SMA50) | $19.25 |
| 100 Day Moving Average (SMA100) | $21.06 |
| 200 Day Moving Average (SMA200) | $21.26 |
Neurogene Statistics
| Average Volume (30 Days) | 188.07K |
|---|---|
| P/E Ratio (Current) | -3.46 |
| EPS (Current) | -$5.50 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$78.41M |
| Cash Ratio | 4.83 |
| Current Ratio | 18.39 |
| Quick Ratio | 18.39 |
| Debt to Equity | 0.00 |
| Enterprise Value | $224.11M |
| EV to EBITDA | -2.38 |
| EV to Sales | — |
| Price to Book | 1.11 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.30% |
| Return on Equity | -0.32% |
Neurogene Stock Splits
There has been 1 stock split for Neurogene (NGNE). The reverse stock split occured on September 25, 2023 and reduced the outstanding shares at a ratio of 5:1.
| Date | Type | Ratio |
|---|---|---|
| Sep 25, 2023 | Reverse | 5:1 |
Neurogene Dividends
There have been no dividends for Neurogene (NGNE).